Health Care & Life Sciences » Biotechnology | Charles River Laboratories International Inc.

Charles River Laboratories International Inc. | Mutual Funds

Mutual Funds that own Charles River Laboratories International Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
iShares Core S&P Mid Cap ETF
1,309,179
2.73%
1,056
0.32%
09/06/2018
Vanguard Small Cap Index Fund
1,205,651
2.5%
15,892
0.15%
07/31/2018
Vanguard Total Stock Market Index Fund
1,197,244
2.49%
1,334
0.02%
07/31/2018
Wells Fargo Advantage Special Mid Cap Value Fund
1,054,900
2.2%
0
1.47%
07/31/2018
Fidelity Small Cap America Fund
989,720
2.06%
-125,000
6.3%
06/30/2018
Vanguard Small Cap Value Index Fund
757,417
1.58%
8,034
0.28%
07/31/2018
Vanguard Extended Market Index Fund
635,398
1.32%
0
0.11%
07/31/2018
First Trust NYSE Arca Biotechnology Index Fund
596,076
1.24%
0
3.18%
09/05/2018
Vanguard Strategic Equity Fund
554,833
1.15%
9,288
0.86%
06/30/2018
SPDR S&P Mid Cap 400 ETF Trust
547,392
1.13%
0
0.32%
09/05/2018

About Charles River Laboratories International

View Profile
Address
251 Ballardvale Street
Wilmington Massachusetts 01887
United States
Employees -
Website http://www.criver.com
Updated 07/08/2019
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following business segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.